Medical treatment of cystoid macular edema

Ocular Immunology and Inflammation

Volumn 10, Issue 4, 2002, Pages 239-246

  Rothova, Aniki ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cystoid macular edema; Treatment; Uveitis

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; CYCLOSPORIN; FLUOCINOLONE ACETONIDE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; TRIAMCINOLONE;

ALGORITHM; CANCER; CANCER RISK; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDLINE; PRACTICE GUIDELINE; RETINA MACULA CYSTOID EDEMA; REVIEW; SIDE EFFECT; TREATMENT PLANNING; UVEITIS; VISUAL ACUITY; VITRECTOMY;

ANTI-INFLAMMATORY AGENTS; HUMANS; MACULAR EDEMA, CYSTOID; UVEITIS; VISION DISORDERS; VITRECTOMY;

EID: 0037998871     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1076/ocii.10.4.239.15589     Document Type: Review

References (63)

1. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332-336.
2. Bresnick GH. Diabetic macular edema. Ophthalmology. 1986;93:989-997.
3. Weinberg DV, Seddon JM. Venous occlusive diseases of the retina. In: Albert DM, Jacobiec FA, editors. Principles and practise of ophthalmology. Philadelphia, PA: WB Saunders, 1994;735-746.
4. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study on diabetic retinopathy IV. Diabetic macular edema. Ophthalmology. 1984;91:1464-1474.
5. Marmor MF. Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol. 1999;97:239-249.
6. Suttorp-Schulten MS, et al. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844-848.
7. Klein R, Klein BEK, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91:1-8.
8. Coscas G, Gaudric A. Natural course of nonaphakic cystoid macular edema. Surv Ophthalmol. 1984;28(Suppl):471-484.
9. Bentley CR, Stanford MR, Shilling JS, Sanders MD, Graham EM. Macular ischaemia in posterior uveitis. Eye. 1993;7:411-414.
10. Hikichi T, Trempe CL. Role of the vitreous in the prognosis of peripheral uveitis. Am J Ophthalmol. 1993;116:401-405.
11. Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity. Ophthalmology. 1987;94:1134-1139.
12. Freeman G. Cystoid macular oedema in uveitis: an unsolved problem. Eye. 2001;15:12-17.
13. Rojas B, Zafirakis P, Christen W, Markomichelakis NN, Foster CS. Medical treatment of macular edema in patients with uveitis. Doc Ophthalmol. 1999;97:399-407.
14. Yoshikawa K, Kotake S, Ichiishi A, Sasamoto Y, Kosaka S, Matsuda H. Posterior sub-tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1995;39:71-76.
15. Nussenblatt RB, de Smet MD, Rubin B, Freidlin V, Whitcup SM, Davis J, Herman D, Bloom JN, Sran PK, Whitcher S, et al. A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin. Am J Ophthalmol. 1993;115:583-591.
16. Guex-Crosier Y, Othenin-Girard P, Herbort CP. Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema. Klin Monatsbl Augenheilkd. 1992;200:367-373.
17. Nussenblatt RB, Palestine AG, Chan CC, Stevens Jr G, Mellow SD, Green SB. Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol. 1991;112:138-146.
18. Jennings T, Rusin MM, Tessler HH, Cunha-Vaz JG. Posterior sub-tenon's injections of corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol. 1988;32:385-391.
19. Zierhut M, Thiel HJ, Schlote T. Treatment of uveitic macular edema with acetazolamide. Doc Ophthalmol. 1999;97:409-413.
20. Wolfensberger TJ. The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol. 1999;97:387-397.
21. Schilling H, Pauleikhoff D, Schrenk M, Wessing A. Therapy of cystoid diffuse macular edema after uveitis and cataract surgery with the carbonic anhydrase inhibitor acetazolamide (Diamox). Klin Monatsbl Augenheilkd. 993;202:206-211.
22. Whitcup SM, Csaky KG, Podgor MJ, Chew EY, Perry CH, Nussenblatt RB. A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. Ophthalmology. 1996;103:1054-1062.
23. Cox SN, Hay E, Bird AC. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol. 1988;106:1190-1195.
24. Dick AD. The treatment of chronic uveitic macular oedema. Br J Ophthalmol. 1994;78:1-2.
25. Suttorp-Schulten MS, Riemslag FC, Rothova A, van der Kley AJ, Riemslag FC. Long-term effect of repeated hyperbaric oxygen therapy on visual acuity in inflammatory cystoid macular oedema. Br J Ophthalmol. 1997;81:329.
26. Kuijpers RW, Baarsma S, van Hagen PM. Treatment of cystoid macular edema with octreotide. N Engl J Med. 1998;338:624-626.
27. Lardenoye CW, van Schooneveld MJ, Frits Treffers W, Rothova A. Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome. Br J Ophthalmol. 1998;82:1013-1016.
28. Suttorp-Schulten MS, Feron E, Postema F, Kijlstra A, Rothova A. Macular grid laser photocoagulation in uveitis. Br J Ophthalmol. 1995;79:821-824.
29. Stavrou P, Baltatzis S, Letko E, Samson CM, Christen W, Foster CS. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflam. 2001;9:141-151.
30. Wiechens B, Nolle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol. 2001;239:474-481.
31. Kiryu J, Kita M, Tanabe T, Yamashiro K, Miyamoto N, Ieki Y. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology. 2001;108:1140-1144.
32. Aylward GW. The place of vitreoretinal surgery in the treatment of macular oedema. Doc Ophthalmol. 1999;97:433-438.
33. Guex-Crosier Y, Othenin-Girard P, Herbort CP. Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema. Klin Monatsbl Augenheilkd. 1992;200:367-373.
34. Ozerdem U, Levi L, Cheng L, Song M, Scher C, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol. 2000;130:240-241.
35. Weijtens O, van der Sluijs FA, Schoemaker RC, Lentjes EGWM, Cohen AF, Romijn FPHTM, van Meurs JC. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol. 1997;123:358-363.
36. Freeman WR, Green RL, Smith RE. Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol. 1987;103:281-288.
37. Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR. A comparison of retrobulbar versus sub-tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology. 1997;104:2003-2008.
38. Young SY, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol. 2001;29:2-6.
39. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology. 2001;108:765-772.
40. Jaffe GJ, Ben-Nun J, Guo H, Dunn JP, Ashton P. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology. 2000;107:2024-2033.
41. Tamesis RR, Rodriguez A, Christen WG, Akova YA, Messmer E, Foster CS. Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. Ophthalmology. 1996;103:768-775.
42. Lane L, Tamesis R, Rodriguez A, Christen W, Akova YA, Messmer E, Pedroza-Seres M, Barney N, Foster CS. Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease. Ophthalmology. 1995;102:1530-1535.
43. Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986;104:847-851.
44. Shaikh S, Blumenkranz MS. Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy. Retina. 2001;21:176-178.
45. Abe T, Hayasaka S, Nagaki Y, Kadoi C, Matsumoto M, Hayasaka Y. Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone. J Cataract Refract Surg. 1999;25:1286-1288.
46. Krott R, Heller R, Aisenbrey S, Bartz-Schmidt KU. Adjunctive hyperbaric oxygenation in macular edema of vascular origin. Undersea Hyperb Med. 2000;27:195-204.
47. Kiryu J, Ogura Y. Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica. 1996;210:168-170.
48. Miyamoto H, Ogura Y, Honda Y. Hyperbaric oxygen treatment for macular edema after retinal vein occlusion-fluorescein angiographic findings and visual prognosis. Nippon Ganka Gakkai Zasshi. 1995;99:220-225.
49. Suttorp-Schulten MS, Riemslag FC, Rothova A, van der Kley AJ. Long-term effect of repeated hyperbaric oxygen therapy on visual acuity in inflammatory cystoid macular oedema. Br J Ophthalmol. 1997;81:329.
50. Stavrou P, Baltatzis S, Letko E, Samson CM, Christen W, Foster CS. Pars plana vitrectomy in patients with intermediate uveitis. Ocul Immunol Inflam. 2001;9:141-151.
51. Bovey EH, Herbort CP. Vitrectomy in the management of uveitis. Ocul Immunol Inflam. 2000;8:285-291.
52. Thumann G, Bartz-Schmidt KU, Esser P, Walter P, Kirchhof B, Krott R, Brunner R, Heimann K. Vitrectomy in treatment of eyes with complicated uveitis. Klin Monatsbl Augenheilkd. 1997;211:241-244.
53. Wiechens B, Nolle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol. 2001;239:474-481.
54. Verbraeken H. Therapeutic pars plana vitrectomy for chronic uveitis: a retrospective study of the long-term results. Graefes Arch Clin Exp Ophthalmol. 1996;234:288-293.
55. Dugel PU, Rao NA, Ozler S, Liggett PE, Smith RE. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study. Ophthalmology. 1992;99:1535-1541.
56. Heiligenhaus A, Bornfeld N, Wessing A. Long-term results of pars plana vitrectomy in the management of intermediate uveitis. Curr Opin Ophthalmol. 1996;7:77-79.
57. Josephberg RG, Kanter ED, Jaffee RM. A fluorescein angiographic study of patients with pars planitis and peripheral exudation (snowbanking) before and after cryopexy. Ophthalmology. 1994;101:1262-1266.
58. Pulido JS, Mieler WF, Walton D, Kuhn E, Postel E, Hartz A, Jampol LM, Weinberg DV, Logani S. Results of peripheral laser photocoagulation in pars planitis. Trans Am Ophthalmol Soc. 1998;96:127-137.
59. Bonnet M, Moron Morel F. Diathermy and cryotherapy of the pars plana in the treatment of pars planitis. Long-term evaluation. J Fr Ophtalmol. 1985;8:37-41.
60. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology. 1996;103:551-560.
61. The Central Vein Occlusion Study Group M report. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology. 1995;102:1425-1433.
62. Lardenoye CW, Probst K, DeLint PJ, Rothova A. Photoreceptor function in eyes with macular edema. Invest Ophthalmol Vis Sci. 2000;41:4048-4053.
63. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920-927.